Grant: Discovery Grants Program - Individual
University of Toronto
$33,000.00
Determinants of the functional antiviral response in the yellow fever mosquito, a major vector of arboviruses
EF 2024-25
Résumé
This proposal focuses on arthropod-borne viruses (arboviruses) that must infect mosquitoes for transmission to humans. Several arboviruses, such as chikungunya, Zika, yellow fever, and dengue, have recently re-emerged or expanded their geographic range. Essentially all RNA viruses, when arboviruses enter a human or mosquito cell their RNA genomes interact with wildly disparate RNAs and RNA binding proteins. Crucially, mosquitoes rely on an RNA-based antiviral response, in which mosquito RNA binding proteins co-opt the viral RNA itself to combat arboviruses. This response, termed RNA interference (RNAi), is a widespread strategy for defending against viral infection among invertebrates. Humans retain RNAi capabilities, which is often used to alter gene expression in human cells in research. However, the antiviral function of RNAi has largely been cast aside in favor of protein-based immune responses in humans. Consequently, arboviruses cope with highly divergent immune responses, but it is unclear how and if RNA- versus protein-based immune responses impact arbovirus infection outcomes. While humans become sick but often clear arboviruses, mosquitoes remain infected for life, happily feeding and infecting new hosts. Antiviral RNAi thus reduces, but does not eliminate, arboviral infections in mosquitoes.
Antiviral RNAi during arbovirus infection of mosquitoes has been intensely studied. Yet the limited experimental and computational tools available for studying RNAi in mosquitoes have been obstacles in understanding which factors contribute to a potent defense against arboviruses. The yellow fever mosquito, Aedes (Ae.) aegypti, is a major transmitter of arboviruses. I established new techniques to map the RNAi response with high resolution in this mosquito to identify the viral RNAs the mosquito hijacks to defend itself. Therefore, Ae. aegypti is a prime target in which to better understand the RNA-mediated antiviral response against arboviruses.
Using these methods, this proposal will answer the following questions: 1) what factors in antiviral RNAi determine the effectiveness of the mosquito anti-arboviral response? 2) does this response change after initial infection, as the virus establishes a persistent, non-lethal presence in the mosquito? 3) can antiviral RNAi mediate immune memory to protect individual mosquitoes or populations from re-infection with similar viruses? In all, this proposal will uncover determinants of a successful RNAi defense against arboviruses in a biologically relevant context, the yellow fever mosquito. As the geographic range of mosquitoes expands worldwide and new mosquito-borne viruses emerge, the proposed studies will shed much-needed light on key aspects of the mosquito anti-viral defense. These findings could also facilitate insights into this prevalent antiviral defense in other organisms. Finally, the outcomes of this research may increase our ability to manipulate RNAi systems in biotechnology and research.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2023-05507
Name nom
Rozen-Gagnon, Kathryn
Department département
Molecular Genetics
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2023
Award amount
33000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5202
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Virology
Research subject fr
Virologie
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Determinants of the functional antiviral response in the yellow fever mosquito, a major vector of arboviruses
Keywords
rna interference; sirna pathway; rna viruses; aedes aegypti; antiviral defense; immunological memory; viral persistence; innate immunity; arboviruses; ago-clip
Application summary
This proposal focuses on arthropod-borne viruses (arboviruses) that must infect mosquitoes for transmission to humans. Several arboviruses, such as chikungunya, Zika, yellow fever, and dengue, have recently re-emerged or expanded their geographic range. Essentially all RNA viruses, when arboviruses enter a human or mosquito cell their RNA genomes interact with wildly disparate RNAs and RNA binding proteins. Crucially, mosquitoes rely on an RNA-based antiviral response, in which mosquito RNA binding proteins co-opt the viral RNA itself to combat arboviruses. This response, termed RNA interference (RNAi), is a widespread strategy for defending against viral infection among invertebrates. Humans retain RNAi capabilities, which is often used to alter gene expression in human cells in research. However, the antiviral function of RNAi has largely been cast aside in favor of protein-based immune responses in humans. Consequently, arboviruses cope with highly divergent immune responses, but it is unclear how and if RNA- versus protein-based immune responses impact arbovirus infection outcomes. While humans become sick but often clear arboviruses, mosquitoes remain infected for life, happily feeding and infecting new hosts. Antiviral RNAi thus reduces, but does not eliminate, arboviral infections in mosquitoes.
Antiviral RNAi during arbovirus infection of mosquitoes has been intensely studied. Yet the limited experimental and computational tools available for studying RNAi in mosquitoes have been obstacles in understanding which factors contribute to a potent defense against arboviruses. The yellow fever mosquito, Aedes (Ae.) aegypti, is a major transmitter of arboviruses. I established new techniques to map the RNAi response with high resolution in this mosquito to identify the viral RNAs the mosquito hijacks to defend itself. Therefore, Ae. aegypti is a prime target in which to better understand the RNA-mediated antiviral response against arboviruses.
Using these methods, this proposal will answer the following questions: 1) what factors in antiviral RNAi determine the effectiveness of the mosquito anti-arboviral response? 2) does this response change after initial infection, as the virus establishes a persistent, non-lethal presence in the mosquito? 3) can antiviral RNAi mediate immune memory to protect individual mosquitoes or populations from re-infection with similar viruses? In all, this proposal will uncover determinants of a successful RNAi defense against arboviruses in a biologically relevant context, the yellow fever mosquito. As the geographic range of mosquitoes expands worldwide and new mosquito-borne viruses emerge, the proposed studies will shed much-needed light on key aspects of the mosquito anti-viral defense. These findings could also facilitate insights into this prevalent antiviral defense in other organisms. Finally, the outcomes of this research may increase our ability to manipulate RNAi systems in biotechnology and research.